TNL Mediagene Regains Compliance with Nasdaq's Bid Price Rule
Rhea-AI Summary
TNL Mediagene (Nasdaq: TNMG) said it received a Nasdaq letter on January 20, 2026 confirming the company has regained compliance with Listing Rule 5550(a)(2) (the Bid Price Rule).
Nasdaq found the company's closing bid price was at least $1.00 per share for 15 consecutive trading days from December 23, 2025 to January 14, 2026. Nasdaq also imposed a one-year Discretionary Panel Monitor under Listing Rule 5815(d)(4)(A). During that year, any new listing deficiency could lead directly to a Delist Determination Letter without a compliance plan or cure period, though the company may request a hearing.
Positive
- Regained compliance with Nasdaq Bid Price Rule on Jan 20, 2026
- Closing bid price >= $1.00 for 15 consecutive trading days (Dec 23, 2025–Jan 14, 2026)
Negative
- One-year Discretionary Panel Monitor imposed under Listing Rule 5815(d)(4)(A)
- During monitoring, any new deficiency can trigger a Delist Determination Letter without a compliance cure period
News Market Reaction
On the day this news was published, TNMG gained 14.20%, reflecting a significant positive market reaction. Argus tracked a peak move of +38.4% during that session. Our momentum scanner triggered 24 alerts that day, indicating elevated trading interest and price volatility. This price movement added approximately $1M to the company's valuation, bringing the market cap to $11M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Momentum scanner shows mixed moves in peers (e.g., DRCT up 23.03%, BHAT down 7.94%) while TNMG’s pre-news price was down 4.34%. Broader Communication Services/Publishing names in the peer list show both gains and losses, pointing to stock-specific dynamics around listing compliance rather than a clear sector rotation.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 13 | Commerce milestone | Positive | -4.7% | GIZMART’s Keychron Nape Pro campaign surpassing ¥300M GMV with 23,602 purchasers. |
| Jan 07 | Government partnership | Positive | -2.9% | Infobahn chosen as lead partner for METI’s global fashion IP program. |
| Jan 06 | AI platform update | Positive | -2.2% | Introduction of NLWeb support to position media as AI-native content infrastructure. |
| Dec 30 | Corporate update | Positive | +6.3% | FY2025 update highlighting $49.1M expected revenue and multiple AI, partnership initiatives. |
| Dec 24 | Listing exception | Positive | -7.3% | Nasdaq Hearings Panel granted continued listing subject to meeting $1 bid price rule. |
Recent positive corporate and strategic announcements have often been followed by negative next-day price reactions, suggesting a pattern of selling into good news.
Over the last month, TNL Mediagene has reported several operational and strategic milestones, including a strong GIZMART crowdfunding outcome on Jan 13, 2026, an AI-focused NLWeb rollout on Jan 6, 2026, and a METI fashion IP partnership on Jan 7, 2026. It also highlighted expected FY2025 revenue of $49.1 million in a corporate update on Dec 30, 2025 and disclosed Nasdaq’s conditional continued listing tied to the $1 Bid Price Rule on Dec 24, 2025. Despite generally constructive news flow, most of these events saw negative 24-hour price reactions, echoing today’s divergence between positive listing compliance news and a weaker pre-news price.
Market Pulse Summary
The stock surged +14.2% in the session following this news. A strong positive reaction aligns with the company’s successful effort to regain compliance with Nasdaq’s $1.00 Bid Price Rule after 15 consecutive trading days above the threshold. Historically, however, TNMG has sometimes seen selling pressure following constructive announcements, which could temper follow-through. The one-year Discretionary Panel Monitor represents an ongoing listing risk, so investors would have needed to watch for any new compliance issues that might trigger an accelerated delisting process.
Key Terms
listing rule 5550(a)(2) regulatory
discretionary panel monitor regulatory
delist determination letter regulatory
hearings panel regulatory
AI-generated analysis. Not financial advice.
The Nasdaq staff made this determination of compliance after the closing bid price of the Company's Ordinary Shares has been at
The Panel also has determined to impose a Discretionary Panel Monitor under Listing Rule 5815(d)(4)(A) for a period of one year from the date of this letter, to make sure that the Company proactively addresses any future potential compliance concerns and demonstrates long-term compliance with Nasdaq's continued listing requirements. If the Panel or the Listing Qualifications Department determines that the Company fails any listing standard during the one-year monitoring period, then, notwithstanding Rule 5810(c)(2), the Company will not be permitted to provide the Listing Qualifications Department with a plan of compliance with respect to any deficiency that arises during the one-year monitoring period, and the Listing Qualifications Department will not be permitted to grant additional time for the Company to regain compliance with respect to any deficiency, nor will the company be afforded an applicable cure or compliance period pursuant to Rule 5810(c)(3). Instead, the Nasdaq staff will issue a Delist Determination Letter and the Company will have an opportunity to request a new hearing with the initial Panel or a newly convened Hearings Panel if the initial Panel is unavailable, as provided by the Listing Rule 5815(d)(4)(C).
About TNL Mediagene
Headquartered in
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are based on beliefs and assumptions and on information currently available to TNL Mediagene. Forward-looking statements generally relate to future events or TNL Mediagene's future financial or operating performance. In some cases, you can identify forward-looking statements by the following words: "may," "will," "could," "would," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "project," "potential," "continue," "ongoing," "target," "seek" or the negative or plural of these words, or other similar expressions that are predictions or indicate future events or prospects, although not all forward-looking statements contain these words. Forward-looking statements in this communication include, but are not limited to, statements about TNL Mediagene's future business plan and growth strategies and statements by TNL Mediagene's management. Any statements that refer to expectations, projections or other characterizations of future events or circumstances, including strategies or plans, are also forward-looking statements. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements. Forward-looking statements in this communication or elsewhere speak only as of the date made. New uncertainties and risks arise from time to time, and it is impossible for TNL Mediagene to predict these events or how they may affect TNL Mediagene. In addition, risks and uncertainties are described in TNL Mediagene's filings with the Securities and Exchange Commission, including the risks and uncertainties set forth under the heading "Risk Factors" in TNL Mediagene's Annual Report on Form 20-F filed on April 30, 2025, as may be supplemented or amended by the TNL Mediagene's Reports of a Foreign Private Issuer on Form 6-K. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. TNL Mediagene cannot assure you that the forward-looking statements in this communication will prove to be accurate. There may be additional risks that TNL Mediagene presently does not know or that TNL Mediagene currently does not believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by TNL Mediagene, its directors, officers or employees or any other person. Except as required by applicable law, TNL Mediagene does not have any duty to, and does not intend to, update or revise the forward-looking statements in this communication or elsewhere after the date of this communication. You should, therefore, not rely on these forward-looking statements as representing the views of TNL Mediagene as of any date subsequent to the date of this communication.
View original content to download multimedia:https://www.prnewswire.com/news-releases/tnl-mediagene-regains-compliance-with-nasdaqs-bid-price-rule-302668235.html
SOURCE TNL Mediagene
FAQ
What did TNL Mediagene (TNMG) announce on January 22, 2026 about Nasdaq compliance?
How did TNMG regain compliance with Nasdaq Listing Rule 5550(a)(2)?
What monitoring conditions did Nasdaq impose on TNMG after regaining compliance?
What happens if TNMG fails a listing standard during the one-year monitoring period?
When did the required 15-consecutive-trading-day compliance period end for TNMG?
